dc.contributor.author | Kaya, Engin | |
dc.contributor.author | Kibar, Yusuf | |
dc.contributor.author | Yilmaz, Sercan | |
dc.contributor.author | Ozcan, Ayhan | |
dc.contributor.author | Kopru, Burak | |
dc.contributor.author | Ebiloglu, Turgay | |
dc.contributor.author | Irkilata, Hasan Cem | |
dc.date.accessioned | 2021-12-21T08:46:56Z | |
dc.date.available | 2021-12-21T08:46:56Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 1911-6470 | |
dc.identifier.issn | 1920-1214 | |
dc.identifier.uri | https://doi.org/10.5489/cuaj.4489 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2131 | |
dc.description.abstract | Introduction: We aimed to evaluate whether or not mitomycin-C (MMC) has an antifibrotic effect on transforming growth factor-beta (TGF-beta)-induced Peyronie's disease (PD) in a rat model. Methods: Eighteen 12-week-old male Sprague-Dawley rats were divide | |
dc.language.iso | English | |
dc.publisher | Canadıan Urologıcal Assocıatıon | |
dc.rights | Green Published, Bronze | |
dc.title | The histopathological effects of intracavernosal mitomycin-C injection in a rat Peyronie's disease model | |
dc.type | Article | |
dc.relation.journal | Cuaj-Canadıan Urologıcal Assocıatıon Journal | |
dc.identifier.issue | 11 | |
dc.identifier.startpage | E441 | |
dc.identifier.endpage | E445 | |
dc.identifier.volume | 11 | |
dc.identifier.doi | 10.5489/cuaj.4489 | |
dc.relation.issue | 11 | |
dc.relation.volume | 11 | |